4108 — Phytohealth Income Statement
0.000.00%
Last trade - 00:00- TWD2.62bn
- TWD2.02bn
- TWD153.56m
- 28
- 13
- 36
- 11
Annual income statement for Phytohealth, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 91.8 | 169 | 135 | 162 | 154 |
| Cost of Revenue | |||||
| Gross Profit | 45.5 | 78.3 | 57 | 67.6 | 64 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 266 | 301 | 292 | 284 | 314 |
| Operating Profit | -174 | -132 | -157 | -122 | -160 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -116 | -95.5 | -115 | -74.1 | -109 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -119 | -95.5 | -115 | -74.1 | -109 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -88.2 | -77.7 | -79.4 | -47.1 | -73.5 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -88.2 | -77.7 | -79.4 | -47.1 | -73.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.6 | -0.397 | -0.4 | -0.236 | -0.369 |
| Dividends per Share |